Sparius Pharmaceuticals Private Limited

Sparius Pharmaceuticals Private Limited - paper in Kalwad, Rajasthan, India. Directors, charges & compliance details.
CIN U21002RJ2023PTC090932 Incorporated 02 November 2023 ROC Jaipur HQ Kalwad, Rajasthan, India
Active Private Limited Company paper
Data last updated
Revenue · FY 2025
₹5.23 Lakh
Latest filing
Net loss · FY 2025
₹23,640
Net margin -4.5%
EBITDA · FY 2025
₹39,935
EBITDA margin 7.6%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹6 Lakh
Secured borrowings
Company age
3 yrs
Est. 2023
Directors on board
2
As per MCA filings

About Sparius Pharmaceuticals Private Limited

Data last updated:

Sparius Pharmaceuticals Private Limited is a private limited company based in Kalwad, Rajasthan, India. It operates in the paper and paper products segment of the paper and packaging sector. It was incorporated on 02 November 2023.

The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U21002RJ2023PTC090932.

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Prashant Singh and Sandeep Prajapat.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Kalwad, Rajasthan.

As per the financials filed for FY 2025, the company reported a revenue of ₹5.23 Lakh. For the same year it recorded a net loss of ₹23,640 (net margin -4.5%) and EBITDA of ₹39,935 (EBITDA margin 7.6%).

As per MCA filings, the company has open charges of ₹6 Lakh on record.

Company Details of Sparius Pharmaceuticals Private Limited
CIN U21002RJ2023PTC090932
Registration Number 090932
Incorporation Date 02 November 2023
ROC Jaipur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    Shop No. G – 23 Ground Floor, Upasana Apna Bazar Moti Nagar Jhotwara Circle, Kalwad, Rajasthan, India – 302012
  • Industry
    Paper, Paper & Paper Products, Manufacturing
Comprehensive company report
Sparius Pharmaceuticals Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full Sparius Pharmaceuticals Private Limited report

Financials, compliance, directors, charges, ownership and filings for Sparius Pharmaceuticals Private Limited in one report.

Financials from FY 2024 Directors & ownership Charges & compliance

Financials of Sparius Pharmaceuticals Private Limited FY 2025 filings available

Sparius Pharmaceuticals Private Limited reported revenue of ₹5.23 Lakh for FY 2025.

Revenue · FY 2025
₹5.23 Lakh
Net loss · FY 2025
₹23,640 margin -4.5%
EBITDA · FY 2025
₹39,935 margin 7.6%

Financial Statement Summary of Sparius Pharmaceuticals Private Limited

MetricsFY 2024-25FY 2023-24
Profit and Loss Statement
Revenue from Operations••••••••
Other Income••••••••
Total Revenue••••••••
Cost of Materials Consumed••••••••
Employee Benefit Expense••••••••
Finance Costs••••••••
Depreciation and Amortisation••••••••
Other Expenses••••••••
Total Expenses••••••••
EBITDA₹39,935••••
Profit Before Tax••••••••
Tax Expense••••••••
Net Profit (PAT)-₹23,640••••
Balance Sheet
Share Capital••••••••
Reserves and Surplus••••••••
Net Worth (Total Equity)••••••••
Long-term Borrowings••••••••
Short-term Borrowings••••••••
Trade Payables••••••••
Total Liabilities••••••••
Fixed Assets••••••••
Investments••••••••
Inventories••••••••
Trade Receivables••••••••
Cash and Bank Balance••••••••
Total Assets••••••••

Financial Ratios of Sparius Pharmaceuticals Private Limited

MetricsFY 2024-25FY 2023-24
Profitability
EBITDA Margin7.6%••••
Net Profit Margin-4.5%••••
Return on Equity (ROE)••••••••
Return on Capital Employed (ROCE)••••••••
Return on Assets (ROA)••••••••
Liquidity and Debt
Current Ratio••••••••
Quick Ratio••••••••
Debt-to-Equity Ratio••••••••
Interest Coverage Ratio••••••••
Efficiency and Growth
Asset Turnover••••••••
Receivable Days••••••••
Payable Days••••••••
Inventory Days••••••••
Revenue Growth••••••••
Net Profit Growth••••••••

Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Sparius Pharmaceuticals are in the company report.

Premium access

Financial statements from FY 2024

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Board of Directors of Sparius Pharmaceuticals Private Limited

Sparius Pharmaceuticals has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Prashant SinghDirector02 Nov 20232 Years 11 MonthsCurrent
Sandeep PrajapatDirector02 Nov 20232 Years 11 MonthsCurrent

Peer Comparison of Sparius Pharmaceuticals Private Limited

Sparius Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Access Pharmaceuticals Private Limited₹5.24 Lakh (FY 2025)••••••••-98.0%••••Ahmedabad, Gujarat, India
Scinder Pharmaceuticals Private Limited₹5.24 Lakh (FY 2023)••••••••-10.0%••••New Delhi, Delhi, India
JPB Pharmaceuticals Private Limited₹5.23 Lakh (FY 2024)••••••••••••Pukhrayan, Uttar Pradesh, India
Medixveda Pharmaceuticals Private Limited₹5.23 Lakh (FY 2025)••••••••52.0%••••Ghaziabad, Uttar Pradesh, India
Indel Pharmaceuticals Private Limited₹5.23 Lakh (FY 2019)••••••••-35.0%••••New Delhi, Delhi, India
Sparius Pharmaceuticals Private Limited this company₹5.23 Lakh (FY 2025)••••••••••••Kalwad, Rajasthan, India
Better Aid Pharmaceuticals Private Limited₹5.2 Lakh (FY 2025)••••••••2.0%••••Kolkata, West Bengal, India
Madsmed Pharmaceuticals Private Limited₹5.19 Lakh (FY 2019)••••••••••••Noida, Uttar Pradesh, India
Fragrance Pharmaceuticals Private Limited₹5.18 Lakh (FY 2022)••••••••-67.0%••••Vadodara, Gujarat, India
Pcag Pharmaceuticals Private Limited₹5.17 Lakh (FY 2024)••••••••••••Delhi, India
Idm Pharmaceuticals Private Limited₹5.17 Lakh (FY 2024)••••••••••••Ponneri, Tamil Nadu, India

Peers are the five companies nearest above and the five nearest below Sparius Pharmaceuticals by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.

Charges & Borrowings of Sparius Pharmaceuticals Private Limited

Open charges
₹6 Lakh
Satisfied charges
None
Breakdown by lending institutions
State Bank of India₹0.06 Cr
Latest charge details
DateLenderAmountStatus
30 Apr 2024State Bank of India₹6 LakhOpen

Total charge records: 1 View all charges

Employees and EPFO Compliance at Sparius Pharmaceuticals Private Limited

Employment history and EPFO contributions of people linked to Sparius Pharmaceuticals.

Premium access

Employee and EPFO history

Monthly headcount, contribution history and filing status are in the company report.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

Recent Activity on Sparius Pharmaceuticals Private Limited

Sparius Pharmaceuticals Private Limited has 2 board changes on record since 2023: 2 appointments. The latest: Prashant Singh was appointed as Director on 02 Nov 2023.

AGM
Sparius Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Sparius Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Jaipur.
Charges
A charge with State Bank Of India amounted to Rs. 6.00 Lakh with Charge ID 100909739 was registered on 30 Apr 2024.
Appointed
Prashant Singh was appointed as Director.
Appointed
Sandeep Prajapat was appointed as Director.
Incorporation
02 Nov 2023
Sparius Pharmaceuticals Private Limited was registered on 02 Nov 2023 with Roc Jaipur & aged 2 years 11 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts for Sparius Pharmaceuticals Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts

Credit ratings, court records and regulatory alerts are in the company report.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Sparius Pharmaceuticals Private Limited

Premium access

MSME payment history

Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Sparius Pharmaceuticals Private Limited

Premium access

Corporate group structure

Parent, subsidiary, associate and joint venture records with holdings are in the company report.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

GST Compliance of Sparius Pharmaceuticals Private Limited

Premium access

GST registrations and filing compliance

State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Sparius Pharmaceuticals Private Limited

Premium access

MCA filings and documents

Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sparius Pharmaceuticals Private Limited

Sparius Pharmaceuticals is an active private limited company based in Kalwad, Rajasthan, India. The company works in paper and paper products, within the paper industry. It was incorporated on 02 November 2023 (3+ years old) and is registered under CIN U21002RJ2023PTC090932.

Sparius Pharmaceuticals reported revenue of ₹5.23 Lakh for FY 2025.

Sparius Pharmaceuticals has 2 current directors:

Sparius Pharmaceuticals reported a net loss of ₹23,640 (net margin -4.5%) and EBITDA of ₹39,935 (EBITDA margin 7.6%) for FY 2025, as per its filed financial statements.

The CIN (Corporate Identification Number) of Sparius Pharmaceuticals is U21002RJ2023PTC090932. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Sparius Pharmaceuticals was incorporated on 02 November 2023, making it 3+ years old. It is registered with the Registrar of Companies, Jaipur.

The peers of Sparius Pharmaceuticals by revenue are Access Pharmaceuticals Private Limited, Scinder Pharmaceuticals Private Limited, JPB Pharmaceuticals Private Limited, Medixveda Pharmaceuticals Private Limited, Indel Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).

Prashant Singh was appointed as Director on 02 Nov 2023. Sandeep Prajapat was appointed as Director on 02 Nov 2023.

The registered office of Sparius Pharmaceuticals is at Shop No. G – 23 Ground Floor, Upasana Apna Bazar Moti Nagar Jhotwara Circle, Kalwad, Rajasthan, India – 302012.

Sparius Pharmaceuticals has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh.

Sparius Pharmaceuticals operates in the paper industry, in the paper and paper products segment.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available